Clinical trials
Withdrawn Carcinoma trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2010 | 1 |
| 2013 | 1 |
| 2016 | 1 |
| 2019 | 1 |
| 2020 | 3 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 13 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bristol-Myers Squibb | 1 |
| Children's National Research Institute | 1 |
| Galectin Therapeutics Inc. | 1 |
| Incyte Biosciences International Sàrl | 1 |
| M.D. Anderson Cancer Center | 1 |
| National Cancer Institute (NCI) | 1 |
| Ohio State University Comprehensive Cancer Center | 1 |
| Robert Ferris | 1 |
| Situs Cancer Research Center | 1 |
| Stanford University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma | 13 |
| Carcinoma, Squamous Cell | 3 |
| Neoplasms | 3 |
| Squamous Cell Carcinoma of Head and Neck | 3 |
| Adenocarcinoma | 2 |
| Recurrence | 2 |
| Sarcoma | 2 |
| Bile Duct Neoplasms | 1 |
| Carcinoma, Hepatocellular | 1 |
| Carcinoma, Non-Small-Cell Lung | 1 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.